DOTA-Pep-1L is a peptide formed by the conjugation of DOTA with Pep-1L, where Pep-1L is a peptide specifically targeting the IL13RA2 receptor. DOTA-Pep-1L is applicable in PET imaging and research focused on tumor-targeted therapy.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
